Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA’s Call for Quality: Revamped GMP Initiative Stresses Cost Savings

16 Jan 2014

• By Kate Rawson

Related Content

FDA/EMA Bioequivalence Collaboration Is Narrow In Scope, Wide In Reach

03 Jan 2014

FDA’s Woodcock to Head Office of Pharmaceutical Quality; New Details Emerge

23 Dec 2013

DoJ and GMPs: A Prosecutor’s Take on Enforcing Product Quality

12 Mar 2013

FDA Quality Profiling: Agency Hopes to Channel Corporate Attention (And Money) To Quality Systems

19 Jul 2013

FDA Could Release GMP Data To Prod Manufacturing Improvements

16 Jul 2013

FDA GMP “Surveillance” Will Link Quality, Compliance Information To Inspections

25 Nov 2013

Culture Clash: FDA Tries to Re-Educate Indian Firms on Processes and Accurate Reporting

01 Oct 2013

Related Companies

Pfizer Inc.

GSK plc

Eli Lilly and Company

H. Lundbeck A/S

H. Lundbeck A/S

Ranbaxy Laboratories Limited

Additional Topics

Regulation BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.